Disc Medicine, Inc.
Records under this name other than the patents Disc Medicine, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,715,916 | Anti-Hemojuvelin (HJV) Antibodies for Treating Myelofibrosis now held by AbbVie Deutschland GmbH & Co. KG In force · Medium confidence | In force | Medium confidence | |
| US 12,715,917 | Methods of Using Anti-Hemojuvelin (HJV) Antibodies for Treating Myelofibrosis now held by AbbVie Deutschland GmbH & Co. KG In force · Medium confidence | In force | Medium confidence | |
| US 12,365,729 | Anti-Hemojuvelin (HJV) Antibodies for Treating Myelofibrosis now held by AbbVie Deutschland GmbH & Co. KG In force · High confidence | In force | High confidence | |
| US 12,497,452 | Anti-Hemojuvelin (HJV) Antibodies for Treating Myelofibrosis now held by AbbVie Deutschland GmbH & Co. KG In force · High confidence | In force | High confidence | |
| US 12,655,210 | Anti-Hemojuvelin (HJV) Antibodies for Treating Anemia of Chronic Disease now held by AbbVie Deutschland GmbH & Co. KG In force · High confidence | In force | High confidence | |
| 17/764,142 | Methods for Treating Myelofibrosis and Related Conditions Abandoned Abandoned Sep 26, 2025 | Abandoned | Abandoned Sep 26, 2025 | |
| 17/764,143 | Methods for Treating Anemia of Chronic Disease Abandoned Abandoned Sep 26, 2025 | Abandoned | Abandoned Sep 26, 2025 | |
| 17/924,672 | Anti-Hemojuvelin (HJV) Antibodies for Treating Myelofibrosis now held by AbbVie Deutschland GmbH & Co. KG Abandoned Abandoned Nov 6, 2025 | Abandoned | Abandoned Nov 6, 2025 | |
| 18/268,107 | Peptidomimetic Matriptase 2 Inhibitors and Uses Thereof Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/280,774 | Compositions and Methods for Treating Anemia Associated with a Ribosomal Disorder Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |